The Enterprise Value as of December 2024 (TTM) for Eupraxia Pharmaceuticals Inc. (EPRXF) is 151.38M

According to Eupraxia Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 151.38M. This represents a change of 36.51% compared to the average of 110.89M of the last 4 quarters.

Eupraxia Pharmaceuticals Inc. (EPRXF) Historical Enterprise Value (quarterly & annually)

How has EPRXF Enterprise Value performed in the past?

The mean historical Enterprise Value of Eupraxia Pharmaceuticals Inc. over the last ten years is 81.69M. The current 151.38M Enterprise Value has changed 18.43% with respect to the historical average. Over the past ten years (40 quarters), EPRXF's Enterprise Value was at its highest in in the June 2023 quarter at 182.42M. The Enterprise Value was at its lowest in in the September 2019 quarter at 0.

Eupraxia Pharmaceuticals Inc. (EPRXF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Eupraxia Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eupraxia Pharmaceuticals Inc. (EPRXF) Average Enterprise Value

How has EPRXF Enterprise Value performed in the past?

The current Enterprise Value of Eupraxia Pharmaceuticals Inc. (EPRXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Eupraxia Pharmaceuticals Inc. (EPRXF) Enterprise Value vs. Peers

How is EPRXF’s Enterprise Value compared to its peers?

Eupraxia Pharmaceuticals Inc.’s Enterprise Value is less than Adynxx, Inc. (0), greater than Ascletis Pharma Inc. (600.00), less than AVAX Technologies, Inc. (2.64B), greater than Eliem Therapeutics, Inc. (-5896313.00), less than Inhibrx Biosciences, Inc. (0), greater than Merrimack Pharmaceuticals, Inc. (15.26M), greater than Celcuity Inc. (-10189682.00), less than Enliven Therapeutics, Inc. (549.83M), less than Transgene SA (1.03B), greater than Champions Oncology, Inc. (76.48M), greater than MAIA Biotechnology, Inc. (112.78M), greater than Lumos Pharma, Inc. (41.72M), greater than Processa Pharmaceuticals, Inc. (24.19M), greater than Alpha Cognition Inc. (50.88K), greater than Acurx Pharmaceuticals, Inc. (34.21M), greater than Fennec Pharmaceuticals Inc. (9.02M), less than null (161.56M),

Build a custom stock screener for Eupraxia Pharmaceuticals Inc. (EPRXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eupraxia Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eupraxia Pharmaceuticals Inc. (EPRXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eupraxia Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.